# Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

> **NCT01158144** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 134 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Endostar
- **DRUG:** Paclitaxel/Carboplatin

## Key facts

- **NCT ID:** NCT01158144
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2011-12
- **Final completion:** 2013-12
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2010-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01158144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01158144, "Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01158144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*